Exhaled markers of pulmonary disease (Q34279117)

1 August 2017

1 reference

title

Exhaled markers of pulmonary disease (English)

1 reference

1 August 2017

Kharitonov SA

1

1 reference

PubMed ID

11401895

1 August 2017

Barnes PJ

series ordinal

2

1 reference

PubMed ID

11401895

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

1 August 2017

1 reference

1 August 2017

163

1 reference

1 August 2017

7

1 reference

1 August 2017

1693-1722

1 reference

Effect of repeated sputum induction on cell counts in normal volunteers.

1 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Clinical aspects of exhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitric oxide and lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

The biology of nitrogen oxides in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled nitric oxide production by nitric oxide synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Expression of inducible nitric oxide in human lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Reactive nitrogen intermediates and antimicrobial activity: role of nitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endogenous airway acidification. Implications for asthma pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nasal nitric oxide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Measurement of exhaled nitric oxide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Expired nitric oxide levels during treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nasal administration of the nitric oxide synthase inhibitor L-NAME induces daytime somnolence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Respiratory nitric oxide levels in experimental human influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased nitric oxide production in the respiratory tract in asymptomatic pacific islanders: an association with skin prick reactivity to house dust mite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled Nitric Oxide, Sensitization, and Exposure to Allergens in Patients with Asthma Who Are Not Taking Inhaled Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased exhaled nitric oxide on days with high outdoor air pollution is of endogenous origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Why does airway inflammation persist? Is it leukotrienes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Inhibitory cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Reduced upper airway nitric oxide in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa--indices for severe perennial nasal allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitric oxide-dependent neutrophil recruitment: role in nasal secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Inhibition of nitric oxide synthase by nasal decongestants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled nitric oxide: a novel biomarker of adverse respiratory health effects in epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

An antiviral mechanism of nitric oxide: inhibition of a viral protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Decreased exhaled nitric oxide in subjects with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitric oxide synthesis in patients with advanced HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNos activity in a murine macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Pathophysiology of changes in absolute lung volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Cross sectional study of exhaled nitric oxide levels following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endogenous Carbon Monoxide Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Endogenous Carbon Monoxide Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Brain nitric oxide synthase is a haemoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Carboxyhemoglobin elevation after exposure to dichloromethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased carbon monoxide in exhaled air of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

The potential of the hydrocarbon breath test as a measure of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Elevation of exhaled ethane concentration in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Oral diet does not alter pulmonary pentane or ethane excretion in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Utility of Breath Ethane as a Noninvasive Biomarker of Vitamin E Status in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Cigarette smoking and ethane exhalation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Application of a new method for analysis of exhaled gas in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Changes in sputum composition between two inductions performed on consecutive days

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Salivary contribution to exhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Pulmonary strategies of antioxidant defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Hydrogen peroxide in exhaled air of healthy children: reference values.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Oxidant activity in expired breath of patients with adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Pulmonary oxidative stress response in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Breath ammonia depletion and its relevance to acidic aerosol exposure studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Quantification of ammonia in human breath by the selected ion flow tube analytical method using H30+ and 02+ precursor ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Urease as a virulence factor in experimental cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Prototype instrument employing a microsensor array for the analysis of organic vapors in exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

NO chemiluminescence in exhaled air: interference of compounds from endogenous or exogenous sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Interrelation between oxygen tension and nitric oxide in the respiratory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Expired air carbon monoxide: a simple breath test of tobacco smoke intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled Isoprene and Acetone in Newborn Infants and in Children with Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

L-arginine increases exhaled nitric oxide in normal human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled Nitric Oxide as a Noninvasive Assessment of Chronic Cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Immunohistochemical Examination of NOS and SOD in Nasal Mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Exhaled Nitric Oxide in Human Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

Expression of Heme Oxygenase Isoenzymes 1 and 2 in Normal and Asthmatic Airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2009041

10.1164/AJRCCM.163.7.2009041

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11401895